Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35


Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials.

Wetterneck CT, Little TE, Rinehart KL, Cervantes ME, Hyde E, Williams M.

J Obsessive Compuls Relat Disord. 2012 Apr;1(2):85-97. doi: 10.1016/j.jocrd.2011.12.001. Epub 2012 Jan 8.


Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.

Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J.

JAMA Psychiatry. 2017 Oct 1;74(10):1011-1020. doi: 10.1001/jamapsychiatry.2017.2432.


Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II.

Conelea CA, Selles RR, Benito KG, Walther MM, Machan JT, Garcia AM, Sapyta J, Morris S, Franklin M, Freeman JB.

J Psychiatr Res. 2017 Sep;92:94-100. doi: 10.1016/j.jpsychires.2017.04.001. Epub 2017 Apr 7.


The Effect of Sertraline on the Quality of Life for Children and Adolescents with Anxiety Disorder.

Çakin Memik N, Karakaya I, Yildiz Ö, Şişmanlar Ş, Çağlayan Ç, Ağaoğlu B.

Noro Psikiyatr Ars. 2014 Mar;51(1):30-39. doi: 10.4274/npa.y6565. Epub 2014 Mar 1.


Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype.

Park MH, Sanders E, Howe M, Singh M, Hallmayer J, Kim E, Chang K.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):458-66. doi: 10.1089/cap.2014.0115. Epub 2015 Jul 28.



McGuire JF, Piacentini J, Lewin AB, Brennan EA, Murphy TK, Storch EA.

Depress Anxiety. 2015 Aug;32(8):580-93. doi: 10.1002/da.22389. Epub 2015 Jun 30.


Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.

Skarphedinsson G, Compton S, Thomsen PH, Weidle B, Dahl K, Nissen JB, Torp NC, Hybel K, Melin KH, Valderhaug R, Wentzel-Larsen T, Ivarsson T.

J Child Adolesc Psychopharmacol. 2015 Jun;25(5):432-9. doi: 10.1089/cap.2014.0167.


Assessment and management of treatment-refractory obsessive-compulsive disorder in children.

Bloch MH, Storch EA.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):251-62. doi: 10.1016/j.jaac.2015.01.011. Epub 2015 Jan 30. Review.


Child/Adolescent anxiety multimodal study: evaluating safety.

Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, Kendall PC, McCracken J, Albano AM, Piacentini J, Riddle MA, Keeton C, Waslick B, Chrisman A, Iyengar S, March JS, Birmaher B.

J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):180-90. doi: 10.1016/j.jaac.2014.12.015. Epub 2014 Dec 31.


Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.

Skarphedinsson G, Weidle B, Thomsen PH, Dahl K, Torp NC, Nissen JB, Melin KH, Hybel K, Valderhaug R, Wentzel-Larsen T, Compton SN, Ivarsson T.

Eur Child Adolesc Psychiatry. 2015 May;24(5):591-602. doi: 10.1007/s00787-014-0613-0. Epub 2014 Sep 20.


Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.


12-week, placebo-controlled trial of add-on riluzole in the treatment of childhood-onset obsessive-compulsive disorder.

Grant PJ, Joseph LA, Farmer CA, Luckenbaugh DA, Lougee LC, Zarate CA Jr, Swedo SE.

Neuropsychopharmacology. 2014 May;39(6):1453-9. doi: 10.1038/npp.2013.343. Epub 2013 Dec 19.


The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods.

Thomsen PH, Torp NC, Dahl K, Christensen K, Englyst I, Melin KH, Nissen JB, Hybel KA, Valderhaug R, Weidle B, Skarphedinsson G, von Bahr PL, Ivarsson T.

Child Adolesc Psychiatry Ment Health. 2013 Dec 19;7(1):41. doi: 10.1186/1753-2000-7-41.


Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.

De Nadai AS, Storch EA, McGuire JF, Lewin AB, Murphy TK.

J Cent Nerv Syst Dis. 2011 Jun 1;3:125-42. doi: 10.4137/JCNSD.S6616. Print 2011.


Pharmacotherapy for anxiety disorders in children and adolescents.

Kodish I, Rockhill C, Varley C.

Dialogues Clin Neurosci. 2011;13(4):439-52. Review.


Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.

Franklin ME, Sapyta J, Freeman JB, Khanna M, Compton S, Almirall D, Moore P, Choate-Summers M, Garcia A, Edson AL, Foa EB, March JS.

JAMA. 2011 Sep 21;306(11):1224-32. doi: 10.1001/jama.2011.1344. Erratum in: JAMA. 2012 Apr 25;307(16):1694.


Still Struggling: characteristics of youth with OCD who are partial responders to medication treatment.

Freeman J, Sapyta J, Garcia A, Fitzgerald D, Khanna M, Choate-Summers M, Moore P, Chrisman A, Haff N, Naeem A, March J, Franklin M.

Child Psychiatry Hum Dev. 2011 Aug;42(4):424-41. doi: 10.1007/s10578-011-0227-4.


Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).

Garcia AM, Sapyta JJ, Moore PS, Freeman JB, Franklin ME, March JS, Foa EB.

J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1024-33; quiz 1086. doi: 10.1016/j.jaac.2010.06.013. Epub 2010 Sep 6.


Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?

Ronsley R, Elbe D, Smith DH, Garland EJ.

J Can Acad Child Adolesc Psychiatry. 2010 Aug;19(3):218-26.

Supplemental Content

Support Center